SOURCE: Antisoma plc

June 13, 2006 07:11 ET

Antisoma to present at Needham & Company Fifth Annual Biotechnology Conference on 15 June 2006

LONDON, UK -- (MARKET WIRE) -- June 13, 2006 --


13 June 2006, London, UK - Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that its Chief Executive Officer, Glyn Edwards, will be presenting at the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference in New York, USA.

Mr Edwards's presentation is scheduled for 13.00 EST on Thursday, June 15, followed by a 30 minute breakout session. A webcast of the presentation will be available to all on Antisoma's website at www.antisoma.com.

It is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Enquiries:
Margherita
Lupi
+44 (0)20 8799 8200
Communications Manager
Antisoma plc
Background on Antisoma

Based in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information.

Copyright © Hugin ASA 2006. All rights reserved.

Contact Information